We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current AUTL market cap is 885.9M. The company's latest EPS is USD -0.7833 and P/E is -4.25.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.07M | 482k | -858k | 0 | 10.09M |
| Operating Income | -38.55M | -47.38M | -49.09M | -40.89M | -40.36M |
| Net Income | -39.81M | -45.55M | -45.85M | -77.17M | -52.69M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.91M | 1.72M | 2.33M | 6.36M | 1.7M |
| Operating Income | -146.06M | -168.15M | -163.65M | -138.9M | -183.51M |
| Net Income | -123.85M | -142.09M | -142.1M | -148.84M | -208.38M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 459.97M | 450.99M | 406.1M | 375.38M | 901.44M |
| Total Liabilities | 193.05M | 221.66M | 225.58M | 263.91M | 319.41M |
| Total Equity | 266.92M | 229.34M | 180.52M | 111.47M | 582.03M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 303.53M | 294.24M | 405.56M | 490.27M | 375.38M |
| Total Liabilities | 48.69M | 84.21M | 92.24M | 191.6M | 263.91M |
| Total Equity | 254.84M | 210.03M | 313.32M | 298.67M | 111.47M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -42.42M | -80.57M | -120.75M | N/A | -40.51M |
| Investing | -3.62M | -8.01M | -9.51M | N/A | -533k |
| Financing | -691k | -910k | -906k | N/A | 561.44M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -101.48M | -117.76M | -117.86M | -112.31M | -145.59M |
| Investing | -18.67M | -14.68M | -8.86M | -10.84M | -10.99M |
| Financing | 108.86M | 74.42M | 284.06M | 223.61M | -883k |
| Market Cap | 885.9M |
| Price to Earnings Ratio | -4.25 |
| Price to Sales Ratio | 520.31 |
| Price to Cash Ratio | 3.7 |
| Price to Book Ratio | 7.95 |
| Dividend Yield | - |
| Shares Outstanding | 266.04M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 1.76 (44.44%) |
| Company Name | Autolus Therapeutics PLC |
| Address |
191 wood lane london W12 7FP |
| Website | https://www.autolus.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
